Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma

NCT04107103 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

SCCHN

Interventions

DRUG: Combination Product: Nivolumab with Pemetrexed

Sponsor

AHS Cancer Control Alberta

Collaborators

[object Object]